|
Leary, Peter J; Kronmal, Richard A; Bluemke, David A et al. (2018) Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial). Am J Cardiol 121:256-261
|
|
Bristow, Michael R; Enciso, Jorge Silva; Gersh, Bernard J et al. (2016) Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations. JACC Basic Transl Sci 1:180-189
|
|
Lindenfeld, JoAnn; Cleveland Jr, Joseph C; Kao, David P et al. (2016) Sex-related differences in age-associated downregulation of human ventricular myocardial ?1-adrenergic receptors. J Heart Lung Transplant 35:352-361
|
|
Kao, David P; Lowes, Brian D; Gilbert, Edward M et al. (2015) Therapeutic Molecular Phenotype of ?-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. Circ Cardiovasc Genet 8:270-83
|
|
Vehlow, Corinna; Kao, David P; Bristow, Michael R et al. (2015) Visual analysis of biological data-knowledge networks. BMC Bioinformatics 16:135
|
|
Hinterberg, Michael A; Kao, David P; Bristow, Michael R et al. (2015) Peax: interactive visual analysis and exploration of complex clinical phenotype and gene expression association. Pac Symp Biocomput :419-30
|
|
Taylor, Mathew R; Sun, Albert Y; Davis, Gordon et al. (2014) Race, common genetic variation, and therapeutic response disparities in heart failure. JACC Heart Fail 2:561-72
|
|
Aleong, Ryan G; Sauer, William H; Davis, Gordon et al. (2013) Prevention of atrial fibrillation by bucindolol is dependent on the beta?389 Arg/Gly adrenergic receptor polymorphism. JACC Heart Fail 1:338-344
|
|
O'Connor, Christopher M; Fiuzat, Mona; Carson, Peter E et al. (2012) Combinatorial pharmacogenetic interactions of bucindolol and ?1, ?2C adrenergic receptor polymorphisms. PLoS One 7:e44324
|
|
Port, J David; Bristow, Michael R (2011) Aptamer therapy for heart failure? Circ Res 109:982-3
|
Showing the most recent 10 out of 39 publications
